8-KLeadership ChangesExhibits & Filings

IDEXX LABORATORIES INC /DE 8-K Report, Executive Changes (Mar 11, 2014)

Filed March 11, 2014For Securities:IDXX

Summary

IDEXX Laboratories, Inc. (IDXX) filed an 8-K on March 11, 2014, to report the election of Daniel M. Junius as an independent director to its Board of Directors. Mr. Junius will serve on the audit committee and his term is expected to end at the 2015 annual meeting, with a potential three-year term expiring in 2018. This appointment addresses a vacancy within Class I of the Board. Mr. Junius's compensation will align with that of other non-employee directors, including prorated cash fees for the current quarter and annual stock unit and stock option grants. The company also furnished a press release related to this appointment as an exhibit to the filing. This filing does not contain significant financial updates but focuses on corporate governance.

Key Highlights

  • 1IDEXX Laboratories appointed Daniel M. Junius as a new independent director on March 11, 2014.
  • 2Mr. Junius has been appointed as a member of the company's audit committee.
  • 3His election fills a vacancy in Class I of the Board of Directors.
  • 4Mr. Junius's term is expected to run until the 2015 annual meeting, with a potential re-election for a three-year term ending in 2018.
  • 5Non-employee director compensation, including stock grants, will be provided to Mr. Junius.
  • 6A press release announcing Mr. Junius's appointment is included as an exhibit.

Frequently Asked Questions

The main purpose of this 8-K filing is to announce the election of Daniel M. Junius as a new independent director to IDEXX Laboratories' Board of Directors and his appointment to the audit committee.

Mr. Junius's current term is expected to end at the 2015 annual meeting of stockholders. He is expected to stand for election for a three-year term expiring in 2018.

Mr. Junius will receive the standard compensation for non-employee directors, which includes prorated cash fees for the current quarter and annual stock unit and stock option grants, similar to other directors.

No, this 8-K filing does not contain any financial statements or updates on the company's financial performance. It is solely focused on a change in the composition of the Board of Directors.